^
5ms
EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer (clinicaltrials.gov)
P1, N=30, Recruiting, Second Affiliated Hospital of Guangzhou Medical University | Trial completion date: May 2025 --> May 2035 | Trial primary completion date: May 2025 --> May 2030
Trial completion date • Trial primary completion date • Metastases
|
EGFR (Epidermal growth factor receptor) • CD276 (CD276 Molecule)
|
Undisclosed EGFR/B7H3 CAR-T
over2years
EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer (clinicaltrials.gov)
P1, N=30, Recruiting, Second Affiliated Hospital of Guangzhou Medical University
New P1 trial
|
EGFR (Epidermal growth factor receptor) • CD276 (CD276 Molecule)
|
EGFR expression • CD276 expression
|
Undisclosed EGFR/B7H3 CAR-T